nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlodipine—CYP1A1—Dacarbazine—muscle cancer	0.142	0.196	CbGbCtD
Amlodipine—CYP1A2—Dacarbazine—muscle cancer	0.0633	0.0875	CbGbCtD
Amlodipine—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.0605	0.0837	CbGbCtD
Amlodipine—CYP3A7—Vincristine—muscle cancer	0.0605	0.0837	CbGbCtD
Amlodipine—ABCB1—Dactinomycin—muscle cancer	0.048	0.0663	CbGbCtD
Amlodipine—CYP3A5—Vincristine—muscle cancer	0.0454	0.0628	CbGbCtD
Amlodipine—CYP3A5—Etoposide—muscle cancer	0.0416	0.0575	CbGbCtD
Amlodipine—CYP2C8—Etoposide—muscle cancer	0.04	0.0553	CbGbCtD
Amlodipine—CACNA1S—pes—muscle cancer	0.0378	0.305	CbGeAlD
Amlodipine—CYP2B6—Doxorubicin—muscle cancer	0.036	0.0498	CbGbCtD
Amlodipine—CYP1A2—Etoposide—muscle cancer	0.031	0.0428	CbGbCtD
Amlodipine—ABCB1—Vincristine—muscle cancer	0.0296	0.0409	CbGbCtD
Amlodipine—ABCB1—Etoposide—muscle cancer	0.0271	0.0374	CbGbCtD
Amlodipine—ABCB1—Doxorubicin—muscle cancer	0.0185	0.0255	CbGbCtD
Amlodipine—ABCB1—Methotrexate—muscle cancer	0.0179	0.0247	CbGbCtD
Amlodipine—CYP3A4—Vincristine—muscle cancer	0.0177	0.0245	CbGbCtD
Amlodipine—CYP2D6—Doxorubicin—muscle cancer	0.0174	0.0241	CbGbCtD
Amlodipine—CYP3A4—Etoposide—muscle cancer	0.0162	0.0224	CbGbCtD
Amlodipine—CYP3A4—Doxorubicin—muscle cancer	0.0111	0.0153	CbGbCtD
Amlodipine—CACNA2D3—tendon—muscle cancer	0.00336	0.0271	CbGeAlD
Amlodipine—CACNA2D3—bone marrow—muscle cancer	0.00325	0.0262	CbGeAlD
Amlodipine—SMPD1—renal system—muscle cancer	0.00325	0.0262	CbGeAlD
Amlodipine—CACNA2D3—vagina—muscle cancer	0.00311	0.0251	CbGeAlD
Amlodipine—SMPD1—cardiac atrium—muscle cancer	0.00291	0.0235	CbGeAlD
Amlodipine—CACNA1S—tendon—muscle cancer	0.00289	0.0233	CbGeAlD
Amlodipine—CACNA2D3—head—muscle cancer	0.00288	0.0232	CbGeAlD
Amlodipine—CACNA2D3—testis—muscle cancer	0.00278	0.0224	CbGeAlD
Amlodipine—CACNA1B—head—muscle cancer	0.0027	0.0218	CbGeAlD
Amlodipine—CACNA1B—testis—muscle cancer	0.00261	0.021	CbGeAlD
Amlodipine—SMPD1—tendon—muscle cancer	0.00253	0.0204	CbGeAlD
Amlodipine—SMPD1—vagina—muscle cancer	0.00235	0.019	CbGeAlD
Amlodipine—SMPD1—head—muscle cancer	0.00217	0.0175	CbGeAlD
Amlodipine—SMPD1—testis—muscle cancer	0.0021	0.0169	CbGeAlD
Amlodipine—CACNB2—cardiac atrium—muscle cancer	0.002	0.0161	CbGeAlD
Amlodipine—CACNA1C—smooth muscle tissue—muscle cancer	0.00187	0.0151	CbGeAlD
Amlodipine—CACNA1D—cardiac atrium—muscle cancer	0.00174	0.0141	CbGeAlD
Amlodipine—CACNB2—tendon—muscle cancer	0.00174	0.014	CbGeAlD
Amlodipine—CACNA2D1—tendon—muscle cancer	0.00163	0.0132	CbGeAlD
Amlodipine—CACNB2—vagina—muscle cancer	0.00161	0.013	CbGeAlD
Amlodipine—CACNA1C—cardiac atrium—muscle cancer	0.00161	0.013	CbGeAlD
Amlodipine—CA1—renal system—muscle cancer	0.00159	0.0128	CbGeAlD
Amlodipine—CACNA2D1—bone marrow—muscle cancer	0.00158	0.0128	CbGeAlD
Amlodipine—CACNA2D1—vagina—muscle cancer	0.00152	0.0122	CbGeAlD
Amlodipine—CACNB2—head—muscle cancer	0.00149	0.012	CbGeAlD
Amlodipine—CACNB2—testis—muscle cancer	0.00144	0.0116	CbGeAlD
Amlodipine—CACNA2D1—head—muscle cancer	0.0014	0.0113	CbGeAlD
Amlodipine—CACNA2D1—testis—muscle cancer	0.00135	0.0109	CbGeAlD
Amlodipine—CACNA1D—head—muscle cancer	0.0013	0.0105	CbGeAlD
Amlodipine—CACNA1C—vagina—muscle cancer	0.0013	0.0105	CbGeAlD
Amlodipine—CYP2A6—vagina—muscle cancer	0.00126	0.0102	CbGeAlD
Amlodipine—CACNA1D—testis—muscle cancer	0.00126	0.0102	CbGeAlD
Amlodipine—CACNA1C—head—muscle cancer	0.0012	0.0097	CbGeAlD
Amlodipine—CA1—bone marrow—muscle cancer	0.0012	0.00968	CbGeAlD
Amlodipine—CACNA1C—testis—muscle cancer	0.00116	0.00937	CbGeAlD
Amlodipine—CA1—head—muscle cancer	0.00106	0.00857	CbGeAlD
Amlodipine—CYP2C8—renal system—muscle cancer	0.00098	0.0079	CbGeAlD
Amlodipine—CYP1A2—renal system—muscle cancer	0.000917	0.0074	CbGeAlD
Amlodipine—CYP1A1—renal system—muscle cancer	0.000905	0.0073	CbGeAlD
Amlodipine—CYP3A5—renal system—muscle cancer	0.000884	0.00713	CbGeAlD
Amlodipine—CYP2B6—renal system—muscle cancer	0.000879	0.00709	CbGeAlD
Amlodipine—CACNA2D3—Arrhythmogenic Right Ventricular Cardiomyopathy—DMD—muscle cancer	0.000824	0.0985	CbGpPWpGaD
Amlodipine—CYP1A1—cardiac atrium—muscle cancer	0.00081	0.00653	CbGeAlD
Amlodipine—CYP2C8—vagina—muscle cancer	0.00071	0.00573	CbGeAlD
Amlodipine—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—DMD—muscle cancer	0.000679	0.0812	CbGpPWpGaD
Amlodipine—CYP3A4—renal system—muscle cancer	0.000664	0.00535	CbGeAlD
Amlodipine—CYP1A1—vagina—muscle cancer	0.000655	0.00528	CbGeAlD
Amlodipine—CYP2D6—renal system—muscle cancer	0.000653	0.00527	CbGeAlD
Amlodipine—CYP3A5—vagina—muscle cancer	0.000641	0.00517	CbGeAlD
Amlodipine—CYP2B6—vagina—muscle cancer	0.000637	0.00514	CbGeAlD
Amlodipine—CYP2C8—testis—muscle cancer	0.000633	0.00511	CbGeAlD
Amlodipine—ABCB1—embryo—muscle cancer	0.000621	0.00501	CbGeAlD
Amlodipine—CYP1A1—head—muscle cancer	0.000605	0.00488	CbGeAlD
Amlodipine—CA1—C-MYB transcription factor network—MYF6—muscle cancer	0.00059	0.0706	CbGpPWpGaD
Amlodipine—CYP2B6—head—muscle cancer	0.000588	0.00474	CbGeAlD
Amlodipine—CYP2B6—testis—muscle cancer	0.000568	0.00458	CbGeAlD
Amlodipine—Osteoarthritis—Methotrexate—muscle cancer	0.000509	0.00353	CcSEcCtD
Amlodipine—Diabetes mellitus—Doxorubicin—muscle cancer	0.000506	0.00351	CcSEcCtD
Amlodipine—Nervous system disorder—Vincristine—muscle cancer	0.000505	0.0035	CcSEcCtD
Amlodipine—Thrombocytopenia—Vincristine—muscle cancer	0.000504	0.0035	CcSEcCtD
Amlodipine—Decreased appetite—Dactinomycin—muscle cancer	0.000501	0.00348	CcSEcCtD
Amlodipine—Dysgeusia—Etoposide—muscle cancer	0.000501	0.00347	CcSEcCtD
Amlodipine—Hyperhidrosis—Vincristine—muscle cancer	0.000498	0.00345	CcSEcCtD
Amlodipine—Fatigue—Dactinomycin—muscle cancer	0.000497	0.00345	CcSEcCtD
Amlodipine—Back pain—Etoposide—muscle cancer	0.000495	0.00343	CcSEcCtD
Amlodipine—Pain—Dactinomycin—muscle cancer	0.000493	0.00342	CcSEcCtD
Amlodipine—Vascular purpura—Doxorubicin—muscle cancer	0.000492	0.00341	CcSEcCtD
Amlodipine—Muscle spasms—Etoposide—muscle cancer	0.000492	0.00341	CcSEcCtD
Amlodipine—Anorexia—Vincristine—muscle cancer	0.000491	0.0034	CcSEcCtD
Amlodipine—Eye pain—Doxorubicin—muscle cancer	0.000488	0.00338	CcSEcCtD
Amlodipine—Cardiac failure congestive—Doxorubicin—muscle cancer	0.000486	0.00337	CcSEcCtD
Amlodipine—Mood swings—Methotrexate—muscle cancer	0.000482	0.00334	CcSEcCtD
Amlodipine—Ataxia—Methotrexate—muscle cancer	0.000478	0.00332	CcSEcCtD
Amlodipine—Feeling abnormal—Dactinomycin—muscle cancer	0.000475	0.00329	CcSEcCtD
Amlodipine—Ill-defined disorder—Etoposide—muscle cancer	0.000475	0.00329	CcSEcCtD
Amlodipine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000472	0.00327	CcSEcCtD
Amlodipine—Hot flush—Doxorubicin—muscle cancer	0.000471	0.00326	CcSEcCtD
Amlodipine—ABCB1—renal system—muscle cancer	0.00047	0.00379	CbGeAlD
Amlodipine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000469	0.00325	CcSEcCtD
Amlodipine—Increased appetite—Doxorubicin—muscle cancer	0.000469	0.00325	CcSEcCtD
Amlodipine—Menopausal symptoms—Doxorubicin—muscle cancer	0.000467	0.00324	CcSEcCtD
Amlodipine—Insomnia—Vincristine—muscle cancer	0.000466	0.00323	CcSEcCtD
Amlodipine—Paraesthesia—Vincristine—muscle cancer	0.000463	0.00321	CcSEcCtD
Amlodipine—Malaise—Etoposide—muscle cancer	0.000461	0.0032	CcSEcCtD
Amlodipine—Breast disorder—Methotrexate—muscle cancer	0.00046	0.00319	CcSEcCtD
Amlodipine—Vertigo—Etoposide—muscle cancer	0.000459	0.00319	CcSEcCtD
Amlodipine—Leukopenia—Etoposide—muscle cancer	0.000458	0.00317	CcSEcCtD
Amlodipine—Purpura—Doxorubicin—muscle cancer	0.000457	0.00317	CcSEcCtD
Amlodipine—Abdominal pain—Dactinomycin—muscle cancer	0.000456	0.00316	CcSEcCtD
Amlodipine—Loss of consciousness—Etoposide—muscle cancer	0.000449	0.00312	CcSEcCtD
Amlodipine—Decreased appetite—Vincristine—muscle cancer	0.000448	0.00311	CcSEcCtD
Amlodipine—Cough—Etoposide—muscle cancer	0.000446	0.00309	CcSEcCtD
Amlodipine—Gastrointestinal disorder—Vincristine—muscle cancer	0.000445	0.00308	CcSEcCtD
Amlodipine—Fatigue—Vincristine—muscle cancer	0.000444	0.00308	CcSEcCtD
Amlodipine—Constipation—Vincristine—muscle cancer	0.000441	0.00305	CcSEcCtD
Amlodipine—Pain—Vincristine—muscle cancer	0.000441	0.00305	CcSEcCtD
Amlodipine—Osteoarthritis—Doxorubicin—muscle cancer	0.00044	0.00305	CcSEcCtD
Amlodipine—Diplopia—Doxorubicin—muscle cancer	0.00044	0.00305	CcSEcCtD
Amlodipine—CYP2D6—head—muscle cancer	0.000437	0.00353	CbGeAlD
Amlodipine—Chest pain—Etoposide—muscle cancer	0.000435	0.00302	CcSEcCtD
Amlodipine—Affect lability—Doxorubicin—muscle cancer	0.000434	0.00301	CcSEcCtD
Amlodipine—Migraine—Doxorubicin—muscle cancer	0.000434	0.00301	CcSEcCtD
Amlodipine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000432	0.003	CcSEcCtD
Amlodipine—Pancreatitis—Methotrexate—muscle cancer	0.000431	0.00299	CcSEcCtD
Amlodipine—Discomfort—Etoposide—muscle cancer	0.00043	0.00298	CcSEcCtD
Amlodipine—Hypersensitivity—Dactinomycin—muscle cancer	0.000425	0.00295	CcSEcCtD
Amlodipine—CYP2D6—testis—muscle cancer	0.000422	0.00341	CbGeAlD
Amlodipine—Gastrointestinal pain—Vincristine—muscle cancer	0.000421	0.00292	CcSEcCtD
Amlodipine—Mood swings—Doxorubicin—muscle cancer	0.000417	0.00289	CcSEcCtD
Amlodipine—Ataxia—Doxorubicin—muscle cancer	0.000414	0.00287	CcSEcCtD
Amlodipine—Asthenia—Dactinomycin—muscle cancer	0.000414	0.00287	CcSEcCtD
Amlodipine—Dysuria—Methotrexate—muscle cancer	0.000411	0.00285	CcSEcCtD
Amlodipine—Thrombocytopenia—Etoposide—muscle cancer	0.000409	0.00283	CcSEcCtD
Amlodipine—Tachycardia—Etoposide—muscle cancer	0.000407	0.00282	CcSEcCtD
Amlodipine—Abdominal pain—Vincristine—muscle cancer	0.000407	0.00282	CcSEcCtD
Amlodipine—Skin disorder—Etoposide—muscle cancer	0.000405	0.00281	CcSEcCtD
Amlodipine—Erectile dysfunction—Methotrexate—muscle cancer	0.000405	0.00281	CcSEcCtD
Amlodipine—Dry skin—Doxorubicin—muscle cancer	0.000404	0.0028	CcSEcCtD
Amlodipine—Hyperhidrosis—Etoposide—muscle cancer	0.000403	0.0028	CcSEcCtD
Amlodipine—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000402	0.00279	CcSEcCtD
Amlodipine—Breast disorder—Doxorubicin—muscle cancer	0.000398	0.00276	CcSEcCtD
Amlodipine—Anorexia—Etoposide—muscle cancer	0.000398	0.00276	CcSEcCtD
Amlodipine—Diarrhoea—Dactinomycin—muscle cancer	0.000395	0.00274	CcSEcCtD
Amlodipine—Gastritis—Doxorubicin—muscle cancer	0.00039	0.0027	CcSEcCtD
Amlodipine—Muscular weakness—Doxorubicin—muscle cancer	0.000388	0.00269	CcSEcCtD
Amlodipine—Conjunctivitis—Methotrexate—muscle cancer	0.000381	0.00264	CcSEcCtD
Amlodipine—Dysphagia—Doxorubicin—muscle cancer	0.000381	0.00264	CcSEcCtD
Amlodipine—Hypersensitivity—Vincristine—muscle cancer	0.00038	0.00263	CcSEcCtD
Amlodipine—Paraesthesia—Etoposide—muscle cancer	0.000375	0.0026	CcSEcCtD
Amlodipine—Pancreatitis—Doxorubicin—muscle cancer	0.000373	0.00259	CcSEcCtD
Amlodipine—Dyspnoea—Etoposide—muscle cancer	0.000372	0.00258	CcSEcCtD
Amlodipine—Somnolence—Etoposide—muscle cancer	0.000371	0.00257	CcSEcCtD
Amlodipine—Epistaxis—Methotrexate—muscle cancer	0.00037	0.00256	CcSEcCtD
Amlodipine—Asthenia—Vincristine—muscle cancer	0.00037	0.00256	CcSEcCtD
Amlodipine—Vomiting—Dactinomycin—muscle cancer	0.000367	0.00254	CcSEcCtD
Amlodipine—Rash—Dactinomycin—muscle cancer	0.000364	0.00252	CcSEcCtD
Amlodipine—Decreased appetite—Etoposide—muscle cancer	0.000363	0.00252	CcSEcCtD
Amlodipine—Gastrointestinal disorder—Etoposide—muscle cancer	0.00036	0.0025	CcSEcCtD
Amlodipine—Fatigue—Etoposide—muscle cancer	0.00036	0.00249	CcSEcCtD
Amlodipine—Pain—Etoposide—muscle cancer	0.000357	0.00247	CcSEcCtD
Amlodipine—Constipation—Etoposide—muscle cancer	0.000357	0.00247	CcSEcCtD
Amlodipine—Dysuria—Doxorubicin—muscle cancer	0.000356	0.00247	CcSEcCtD
Amlodipine—ABCB1—bone marrow—muscle cancer	0.000355	0.00287	CbGeAlD
Amlodipine—Haemoglobin—Methotrexate—muscle cancer	0.000354	0.00245	CcSEcCtD
Amlodipine—Diarrhoea—Vincristine—muscle cancer	0.000353	0.00244	CcSEcCtD
Amlodipine—Hepatitis—Methotrexate—muscle cancer	0.000352	0.00244	CcSEcCtD
Amlodipine—Haemorrhage—Methotrexate—muscle cancer	0.000352	0.00244	CcSEcCtD
Amlodipine—Pollakiuria—Doxorubicin—muscle cancer	0.000352	0.00244	CcSEcCtD
Amlodipine—Urinary tract disorder—Methotrexate—muscle cancer	0.000348	0.00241	CcSEcCtD
Amlodipine—Weight increased—Doxorubicin—muscle cancer	0.000346	0.0024	CcSEcCtD
Amlodipine—Urethral disorder—Methotrexate—muscle cancer	0.000345	0.00239	CcSEcCtD
Amlodipine—Weight decreased—Doxorubicin—muscle cancer	0.000344	0.00239	CcSEcCtD
Amlodipine—Feeling abnormal—Etoposide—muscle cancer	0.000344	0.00238	CcSEcCtD
Amlodipine—Hyperglycaemia—Doxorubicin—muscle cancer	0.000343	0.00238	CcSEcCtD
Amlodipine—Nausea—Dactinomycin—muscle cancer	0.000343	0.00237	CcSEcCtD
Amlodipine—Gastrointestinal pain—Etoposide—muscle cancer	0.000341	0.00237	CcSEcCtD
Amlodipine—Dizziness—Vincristine—muscle cancer	0.000341	0.00236	CcSEcCtD
Amlodipine—ABCB1—vagina—muscle cancer	0.00034	0.00275	CbGeAlD
Amlodipine—Visual impairment—Methotrexate—muscle cancer	0.000339	0.00235	CcSEcCtD
Amlodipine—Erythema multiforme—Methotrexate—muscle cancer	0.000333	0.00231	CcSEcCtD
Amlodipine—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000333	0.00231	CcSEcCtD
Amlodipine—Urticaria—Etoposide—muscle cancer	0.000332	0.0023	CcSEcCtD
Amlodipine—Jaundice—Doxorubicin—muscle cancer	0.000331	0.00229	CcSEcCtD
Amlodipine—Abdominal pain—Etoposide—muscle cancer	0.00033	0.00229	CcSEcCtD
Amlodipine—Conjunctivitis—Doxorubicin—muscle cancer	0.00033	0.00229	CcSEcCtD
Amlodipine—Eye disorder—Methotrexate—muscle cancer	0.000329	0.00228	CcSEcCtD
Amlodipine—Tinnitus—Methotrexate—muscle cancer	0.000328	0.00227	CcSEcCtD
Amlodipine—Vomiting—Vincristine—muscle cancer	0.000328	0.00227	CcSEcCtD
Amlodipine—Cardiac disorder—Methotrexate—muscle cancer	0.000327	0.00226	CcSEcCtD
Amlodipine—Rash—Vincristine—muscle cancer	0.000325	0.00225	CcSEcCtD
Amlodipine—Dermatitis—Vincristine—muscle cancer	0.000325	0.00225	CcSEcCtD
Amlodipine—Headache—Vincristine—muscle cancer	0.000323	0.00224	CcSEcCtD
Amlodipine—Epistaxis—Doxorubicin—muscle cancer	0.00032	0.00222	CcSEcCtD
Amlodipine—Angiopathy—Methotrexate—muscle cancer	0.000319	0.00221	CcSEcCtD
Amlodipine—Immune system disorder—Methotrexate—muscle cancer	0.000318	0.0022	CcSEcCtD
Amlodipine—Mediastinal disorder—Methotrexate—muscle cancer	0.000317	0.0022	CcSEcCtD
Amlodipine—Chills—Methotrexate—muscle cancer	0.000316	0.00219	CcSEcCtD
Amlodipine—ABCB1—head—muscle cancer	0.000314	0.00254	CbGeAlD
Amlodipine—Alopecia—Methotrexate—muscle cancer	0.000311	0.00216	CcSEcCtD
Amlodipine—Bradycardia—Doxorubicin—muscle cancer	0.00031	0.00215	CcSEcCtD
Amlodipine—Mental disorder—Methotrexate—muscle cancer	0.000308	0.00214	CcSEcCtD
Amlodipine—Hypersensitivity—Etoposide—muscle cancer	0.000308	0.00213	CcSEcCtD
Amlodipine—Malnutrition—Methotrexate—muscle cancer	0.000306	0.00212	CcSEcCtD
Amlodipine—Haemoglobin—Doxorubicin—muscle cancer	0.000306	0.00212	CcSEcCtD
Amlodipine—Nausea—Vincristine—muscle cancer	0.000306	0.00212	CcSEcCtD
Amlodipine—Rhinitis—Doxorubicin—muscle cancer	0.000305	0.00212	CcSEcCtD
Amlodipine—Haemorrhage—Doxorubicin—muscle cancer	0.000305	0.00211	CcSEcCtD
Amlodipine—Hepatitis—Doxorubicin—muscle cancer	0.000305	0.00211	CcSEcCtD
Amlodipine—ABCB1—testis—muscle cancer	0.000304	0.00245	CbGeAlD
Amlodipine—Hypoaesthesia—Doxorubicin—muscle cancer	0.000303	0.0021	CcSEcCtD
Amlodipine—CACNA1S—Arrhythmogenic Right Ventricular Cardiomyopathy—DMD—muscle cancer	0.000302	0.0362	CbGpPWpGaD
Amlodipine—Urinary tract disorder—Doxorubicin—muscle cancer	0.000301	0.00209	CcSEcCtD
Amlodipine—Oedema peripheral—Doxorubicin—muscle cancer	0.0003	0.00208	CcSEcCtD
Amlodipine—Dysgeusia—Methotrexate—muscle cancer	0.0003	0.00208	CcSEcCtD
Amlodipine—Asthenia—Etoposide—muscle cancer	0.000299	0.00208	CcSEcCtD
Amlodipine—Connective tissue disorder—Doxorubicin—muscle cancer	0.000299	0.00208	CcSEcCtD
Amlodipine—Urethral disorder—Doxorubicin—muscle cancer	0.000299	0.00207	CcSEcCtD
Amlodipine—Back pain—Methotrexate—muscle cancer	0.000296	0.00205	CcSEcCtD
Amlodipine—Pruritus—Etoposide—muscle cancer	0.000295	0.00205	CcSEcCtD
Amlodipine—Visual impairment—Doxorubicin—muscle cancer	0.000294	0.00204	CcSEcCtD
Amlodipine—Erythema multiforme—Doxorubicin—muscle cancer	0.000288	0.002	CcSEcCtD
Amlodipine—Diarrhoea—Etoposide—muscle cancer	0.000286	0.00198	CcSEcCtD
Amlodipine—Eye disorder—Doxorubicin—muscle cancer	0.000285	0.00197	CcSEcCtD
Amlodipine—Ill-defined disorder—Methotrexate—muscle cancer	0.000284	0.00197	CcSEcCtD
Amlodipine—Tinnitus—Doxorubicin—muscle cancer	0.000284	0.00197	CcSEcCtD
Amlodipine—Cardiac disorder—Doxorubicin—muscle cancer	0.000283	0.00196	CcSEcCtD
Amlodipine—Flushing—Doxorubicin—muscle cancer	0.000283	0.00196	CcSEcCtD
Amlodipine—Angiopathy—Doxorubicin—muscle cancer	0.000276	0.00192	CcSEcCtD
Amlodipine—Malaise—Methotrexate—muscle cancer	0.000276	0.00192	CcSEcCtD
Amlodipine—Dizziness—Etoposide—muscle cancer	0.000276	0.00191	CcSEcCtD
Amlodipine—Immune system disorder—Doxorubicin—muscle cancer	0.000275	0.00191	CcSEcCtD
Amlodipine—Vertigo—Methotrexate—muscle cancer	0.000275	0.00191	CcSEcCtD
Amlodipine—Mediastinal disorder—Doxorubicin—muscle cancer	0.000275	0.0019	CcSEcCtD
Amlodipine—Leukopenia—Methotrexate—muscle cancer	0.000274	0.0019	CcSEcCtD
Amlodipine—Chills—Doxorubicin—muscle cancer	0.000273	0.0019	CcSEcCtD
Amlodipine—Arrhythmia—Doxorubicin—muscle cancer	0.000272	0.00189	CcSEcCtD
Amlodipine—Alopecia—Doxorubicin—muscle cancer	0.000269	0.00187	CcSEcCtD
Amlodipine—Cough—Methotrexate—muscle cancer	0.000267	0.00185	CcSEcCtD
Amlodipine—Mental disorder—Doxorubicin—muscle cancer	0.000267	0.00185	CcSEcCtD
Amlodipine—Vomiting—Etoposide—muscle cancer	0.000265	0.00184	CcSEcCtD
Amlodipine—Malnutrition—Doxorubicin—muscle cancer	0.000265	0.00184	CcSEcCtD
Amlodipine—Rash—Etoposide—muscle cancer	0.000263	0.00182	CcSEcCtD
Amlodipine—Dermatitis—Etoposide—muscle cancer	0.000263	0.00182	CcSEcCtD
Amlodipine—Headache—Etoposide—muscle cancer	0.000261	0.00181	CcSEcCtD
Amlodipine—Flatulence—Doxorubicin—muscle cancer	0.000261	0.00181	CcSEcCtD
Amlodipine—Myalgia—Methotrexate—muscle cancer	0.000261	0.00181	CcSEcCtD
Amlodipine—Chest pain—Methotrexate—muscle cancer	0.000261	0.00181	CcSEcCtD
Amlodipine—Arthralgia—Methotrexate—muscle cancer	0.000261	0.00181	CcSEcCtD
Amlodipine—Tension—Doxorubicin—muscle cancer	0.00026	0.0018	CcSEcCtD
Amlodipine—Dysgeusia—Doxorubicin—muscle cancer	0.00026	0.0018	CcSEcCtD
Amlodipine—CACNB2—Arrhythmogenic Right Ventricular Cardiomyopathy—DMD—muscle cancer	0.000259	0.031	CbGpPWpGaD
Amlodipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000259	0.0018	CcSEcCtD
Amlodipine—Discomfort—Methotrexate—muscle cancer	0.000258	0.00179	CcSEcCtD
Amlodipine—Nervousness—Doxorubicin—muscle cancer	0.000258	0.00179	CcSEcCtD
Amlodipine—Back pain—Doxorubicin—muscle cancer	0.000257	0.00178	CcSEcCtD
Amlodipine—Muscle spasms—Doxorubicin—muscle cancer	0.000255	0.00177	CcSEcCtD
Amlodipine—Nausea—Etoposide—muscle cancer	0.000248	0.00172	CcSEcCtD
Amlodipine—Ill-defined disorder—Doxorubicin—muscle cancer	0.000246	0.00171	CcSEcCtD
Amlodipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—DMD—muscle cancer	0.000246	0.0294	CbGpPWpGaD
Amlodipine—Nervous system disorder—Methotrexate—muscle cancer	0.000245	0.0017	CcSEcCtD
Amlodipine—Thrombocytopenia—Methotrexate—muscle cancer	0.000245	0.0017	CcSEcCtD
Amlodipine—Agitation—Doxorubicin—muscle cancer	0.000244	0.00169	CcSEcCtD
Amlodipine—Skin disorder—Methotrexate—muscle cancer	0.000243	0.00168	CcSEcCtD
Amlodipine—Hyperhidrosis—Methotrexate—muscle cancer	0.000242	0.00168	CcSEcCtD
Amlodipine—Malaise—Doxorubicin—muscle cancer	0.000239	0.00166	CcSEcCtD
Amlodipine—Vertigo—Doxorubicin—muscle cancer	0.000238	0.00165	CcSEcCtD
Amlodipine—Anorexia—Methotrexate—muscle cancer	0.000238	0.00165	CcSEcCtD
Amlodipine—Syncope—Doxorubicin—muscle cancer	0.000238	0.00165	CcSEcCtD
Amlodipine—Leukopenia—Doxorubicin—muscle cancer	0.000237	0.00165	CcSEcCtD
Amlodipine—CA1—C-MYB transcription factor network—MYOD1—muscle cancer	0.000235	0.0281	CbGpPWpGaD
Amlodipine—CA1—C-MYB transcription factor network—CD34—muscle cancer	0.000235	0.0281	CbGpPWpGaD
Amlodipine—Palpitations—Doxorubicin—muscle cancer	0.000234	0.00163	CcSEcCtD
Amlodipine—Loss of consciousness—Doxorubicin—muscle cancer	0.000233	0.00162	CcSEcCtD
Amlodipine—Cough—Doxorubicin—muscle cancer	0.000231	0.0016	CcSEcCtD
Amlodipine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000228	0.00158	CcSEcCtD
Amlodipine—Insomnia—Methotrexate—muscle cancer	0.000226	0.00157	CcSEcCtD
Amlodipine—Arthralgia—Doxorubicin—muscle cancer	0.000226	0.00157	CcSEcCtD
Amlodipine—Myalgia—Doxorubicin—muscle cancer	0.000226	0.00157	CcSEcCtD
Amlodipine—Chest pain—Doxorubicin—muscle cancer	0.000226	0.00157	CcSEcCtD
Amlodipine—Anxiety—Doxorubicin—muscle cancer	0.000225	0.00156	CcSEcCtD
Amlodipine—Paraesthesia—Methotrexate—muscle cancer	0.000224	0.00156	CcSEcCtD
Amlodipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000224	0.00155	CcSEcCtD
Amlodipine—Discomfort—Doxorubicin—muscle cancer	0.000223	0.00155	CcSEcCtD
Amlodipine—Dyspnoea—Methotrexate—muscle cancer	0.000223	0.00155	CcSEcCtD
Amlodipine—Somnolence—Methotrexate—muscle cancer	0.000222	0.00154	CcSEcCtD
Amlodipine—Dry mouth—Doxorubicin—muscle cancer	0.000221	0.00153	CcSEcCtD
Amlodipine—Dyspepsia—Methotrexate—muscle cancer	0.00022	0.00153	CcSEcCtD
Amlodipine—Decreased appetite—Methotrexate—muscle cancer	0.000217	0.00151	CcSEcCtD
Amlodipine—Oedema—Doxorubicin—muscle cancer	0.000216	0.0015	CcSEcCtD
Amlodipine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000216	0.0015	CcSEcCtD
Amlodipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—DMD—muscle cancer	0.000216	0.0258	CbGpPWpGaD
Amlodipine—Fatigue—Methotrexate—muscle cancer	0.000216	0.00149	CcSEcCtD
Amlodipine—Pain—Methotrexate—muscle cancer	0.000214	0.00148	CcSEcCtD
Amlodipine—Shock—Doxorubicin—muscle cancer	0.000213	0.00148	CcSEcCtD
Amlodipine—Nervous system disorder—Doxorubicin—muscle cancer	0.000212	0.00147	CcSEcCtD
Amlodipine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000212	0.00147	CcSEcCtD
Amlodipine—Tachycardia—Doxorubicin—muscle cancer	0.000211	0.00146	CcSEcCtD
Amlodipine—Skin disorder—Doxorubicin—muscle cancer	0.00021	0.00146	CcSEcCtD
Amlodipine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000209	0.00145	CcSEcCtD
Amlodipine—Anorexia—Doxorubicin—muscle cancer	0.000206	0.00143	CcSEcCtD
Amlodipine—Feeling abnormal—Methotrexate—muscle cancer	0.000206	0.00143	CcSEcCtD
Amlodipine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000204	0.00142	CcSEcCtD
Amlodipine—Urticaria—Methotrexate—muscle cancer	0.000199	0.00138	CcSEcCtD
Amlodipine—Abdominal pain—Methotrexate—muscle cancer	0.000198	0.00137	CcSEcCtD
Amlodipine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000197	0.00137	CcSEcCtD
Amlodipine—Insomnia—Doxorubicin—muscle cancer	0.000196	0.00136	CcSEcCtD
Amlodipine—Paraesthesia—Doxorubicin—muscle cancer	0.000194	0.00135	CcSEcCtD
Amlodipine—Dyspnoea—Doxorubicin—muscle cancer	0.000193	0.00134	CcSEcCtD
Amlodipine—Somnolence—Doxorubicin—muscle cancer	0.000192	0.00133	CcSEcCtD
Amlodipine—Dyspepsia—Doxorubicin—muscle cancer	0.000191	0.00132	CcSEcCtD
Amlodipine—Decreased appetite—Doxorubicin—muscle cancer	0.000188	0.0013	CcSEcCtD
Amlodipine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000187	0.0013	CcSEcCtD
Amlodipine—Fatigue—Doxorubicin—muscle cancer	0.000187	0.00129	CcSEcCtD
Amlodipine—Pain—Doxorubicin—muscle cancer	0.000185	0.00128	CcSEcCtD
Amlodipine—Constipation—Doxorubicin—muscle cancer	0.000185	0.00128	CcSEcCtD
Amlodipine—Hypersensitivity—Methotrexate—muscle cancer	0.000184	0.00128	CcSEcCtD
Amlodipine—Asthenia—Methotrexate—muscle cancer	0.000179	0.00124	CcSEcCtD
Amlodipine—Feeling abnormal—Doxorubicin—muscle cancer	0.000178	0.00124	CcSEcCtD
Amlodipine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000177	0.00123	CcSEcCtD
Amlodipine—Pruritus—Methotrexate—muscle cancer	0.000177	0.00123	CcSEcCtD
Amlodipine—Urticaria—Doxorubicin—muscle cancer	0.000172	0.00119	CcSEcCtD
Amlodipine—Abdominal pain—Doxorubicin—muscle cancer	0.000171	0.00119	CcSEcCtD
Amlodipine—Diarrhoea—Methotrexate—muscle cancer	0.000171	0.00119	CcSEcCtD
Amlodipine—Dizziness—Methotrexate—muscle cancer	0.000165	0.00115	CcSEcCtD
Amlodipine—Hypersensitivity—Doxorubicin—muscle cancer	0.000159	0.00111	CcSEcCtD
Amlodipine—Vomiting—Methotrexate—muscle cancer	0.000159	0.0011	CcSEcCtD
Amlodipine—Rash—Methotrexate—muscle cancer	0.000158	0.00109	CcSEcCtD
Amlodipine—Dermatitis—Methotrexate—muscle cancer	0.000157	0.00109	CcSEcCtD
Amlodipine—Headache—Methotrexate—muscle cancer	0.000157	0.00109	CcSEcCtD
Amlodipine—Asthenia—Doxorubicin—muscle cancer	0.000155	0.00108	CcSEcCtD
Amlodipine—Pruritus—Doxorubicin—muscle cancer	0.000153	0.00106	CcSEcCtD
Amlodipine—Nausea—Methotrexate—muscle cancer	0.000149	0.00103	CcSEcCtD
Amlodipine—Diarrhoea—Doxorubicin—muscle cancer	0.000148	0.00103	CcSEcCtD
Amlodipine—CACNA1S—Developmental Biology—MYF5—muscle cancer	0.000144	0.0173	CbGpPWpGaD
Amlodipine—CACNA1S—Developmental Biology—MYF6—muscle cancer	0.000144	0.0173	CbGpPWpGaD
Amlodipine—Dizziness—Doxorubicin—muscle cancer	0.000143	0.000992	CcSEcCtD
Amlodipine—Vomiting—Doxorubicin—muscle cancer	0.000138	0.000954	CcSEcCtD
Amlodipine—Rash—Doxorubicin—muscle cancer	0.000136	0.000946	CcSEcCtD
Amlodipine—Dermatitis—Doxorubicin—muscle cancer	0.000136	0.000945	CcSEcCtD
Amlodipine—Headache—Doxorubicin—muscle cancer	0.000136	0.00094	CcSEcCtD
Amlodipine—Nausea—Doxorubicin—muscle cancer	0.000129	0.000891	CcSEcCtD
Amlodipine—CACNB2—Developmental Biology—MYF6—muscle cancer	0.000124	0.0148	CbGpPWpGaD
Amlodipine—CACNB2—Developmental Biology—MYF5—muscle cancer	0.000124	0.0148	CbGpPWpGaD
Amlodipine—CACNA1D—Developmental Biology—MYF6—muscle cancer	0.000117	0.014	CbGpPWpGaD
Amlodipine—CACNA1D—Developmental Biology—MYF5—muscle cancer	0.000117	0.014	CbGpPWpGaD
Amlodipine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—muscle cancer	0.000104	0.0124	CbGpPWpGaD
Amlodipine—CYP2A6—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000103	0.0123	CbGpPWpGaD
Amlodipine—CACNA1C—Developmental Biology—MYF5—muscle cancer	0.000103	0.0123	CbGpPWpGaD
Amlodipine—CACNA1C—Developmental Biology—MYF6—muscle cancer	0.000103	0.0123	CbGpPWpGaD
Amlodipine—CACNA2D3—Transmission across Chemical Synapses—MDM2—muscle cancer	9.72e-05	0.0116	CbGpPWpGaD
Amlodipine—CACNA1S—Developmental Biology—MYOG—muscle cancer	9.3e-05	0.0111	CbGpPWpGaD
Amlodipine—CA1—C-MYB transcription factor network—KIT—muscle cancer	8.99e-05	0.0108	CbGpPWpGaD
Amlodipine—CYP2B6—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	8.32e-05	0.00995	CbGpPWpGaD
Amlodipine—CYP1A1—Melatonin metabolism and effects—FOXO1—muscle cancer	8.31e-05	0.00994	CbGpPWpGaD
Amlodipine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—muscle cancer	8.18e-05	0.00978	CbGpPWpGaD
Amlodipine—CYP3A5—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	8.13e-05	0.00972	CbGpPWpGaD
Amlodipine—CACNB2—Developmental Biology—MYOG—muscle cancer	7.97e-05	0.00953	CbGpPWpGaD
Amlodipine—CACNA1D—Developmental Biology—MYOG—muscle cancer	7.55e-05	0.00903	CbGpPWpGaD
Amlodipine—SMPD1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	7.53e-05	0.00901	CbGpPWpGaD
Amlodipine—CACNA2D3—Neuronal System—MDM2—muscle cancer	7.44e-05	0.0089	CbGpPWpGaD
Amlodipine—CA1—C-MYB transcription factor network—CDKN2A—muscle cancer	7.3e-05	0.00873	CbGpPWpGaD
Amlodipine—CA1—C-MYB transcription factor network—PTGS2—muscle cancer	6.83e-05	0.00816	CbGpPWpGaD
Amlodipine—CACNA1B—Transmission across Chemical Synapses—MDM2—muscle cancer	6.73e-05	0.00805	CbGpPWpGaD
Amlodipine—CACNA1C—Developmental Biology—MYOG—muscle cancer	6.63e-05	0.00793	CbGpPWpGaD
Amlodipine—CYP2D6—Melatonin metabolism and effects—FOXO1—muscle cancer	6.25e-05	0.00748	CbGpPWpGaD
Amlodipine—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	6.13e-05	0.00734	CbGpPWpGaD
Amlodipine—SMPD1—Metabolism—FH—muscle cancer	5.94e-05	0.0071	CbGpPWpGaD
Amlodipine—CACNA1S—Developmental Biology—MYOD1—muscle cancer	5.74e-05	0.00687	CbGpPWpGaD
Amlodipine—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	5.73e-05	0.00685	CbGpPWpGaD
Amlodipine—CYP1A2—Melatonin metabolism and effects—FOXO1—muscle cancer	5.3e-05	0.00634	CbGpPWpGaD
Amlodipine—CACNA1S—Developmental Biology—MED12—muscle cancer	5.25e-05	0.00628	CbGpPWpGaD
Amlodipine—CYP1A1—PPARA activates gene expression—MED12—muscle cancer	5.21e-05	0.00623	CbGpPWpGaD
Amlodipine—CACNA1B—Neuronal System—MDM2—muscle cancer	5.16e-05	0.00617	CbGpPWpGaD
Amlodipine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—muscle cancer	5.1e-05	0.0061	CbGpPWpGaD
Amlodipine—CACNB2—Developmental Biology—MYOD1—muscle cancer	4.92e-05	0.00589	CbGpPWpGaD
Amlodipine—CACNA1D—Developmental Biology—MYOD1—muscle cancer	4.66e-05	0.00558	CbGpPWpGaD
Amlodipine—CACNB2—Developmental Biology—MED12—muscle cancer	4.5e-05	0.00539	CbGpPWpGaD
Amlodipine—CACNA1S—Alzheimers Disease—TP53—muscle cancer	4.3e-05	0.00514	CbGpPWpGaD
Amlodipine—CACNA1D—Developmental Biology—MED12—muscle cancer	4.26e-05	0.0051	CbGpPWpGaD
Amlodipine—CACNA1C—Developmental Biology—MYOD1—muscle cancer	4.1e-05	0.0049	CbGpPWpGaD
Amlodipine—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	3.78e-05	0.00452	CbGpPWpGaD
Amlodipine—CACNA1C—Developmental Biology—MED12—muscle cancer	3.75e-05	0.00448	CbGpPWpGaD
Amlodipine—CA1—Metabolism—FH—muscle cancer	3.67e-05	0.00439	CbGpPWpGaD
Amlodipine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—muscle cancer	3.51e-05	0.0042	CbGpPWpGaD
Amlodipine—CACNA1D—Alzheimers Disease—TP53—muscle cancer	3.49e-05	0.00418	CbGpPWpGaD
Amlodipine—CYP2A6—Fluoropyrimidine Activity—TP53—muscle cancer	3.46e-05	0.00414	CbGpPWpGaD
Amlodipine—CYP1A1—Tryptophan metabolism—MDM2—muscle cancer	3.45e-05	0.00412	CbGpPWpGaD
Amlodipine—SMPD1—Metabolism—MED12—muscle cancer	3.35e-05	0.00401	CbGpPWpGaD
Amlodipine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—muscle cancer	3.32e-05	0.00398	CbGpPWpGaD
Amlodipine—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	3.32e-05	0.00397	CbGpPWpGaD
Amlodipine—CACNB2—Metabolism—FH—muscle cancer	3.17e-05	0.00379	CbGpPWpGaD
Amlodipine—CYP1A1—Arachidonic acid metabolism—PTGS2—muscle cancer	3.11e-05	0.00372	CbGpPWpGaD
Amlodipine—CACNA1C—Alzheimers Disease—TP53—muscle cancer	3.07e-05	0.00367	CbGpPWpGaD
Amlodipine—SMPD1—Metabolism—ENO2—muscle cancer	3.06e-05	0.00366	CbGpPWpGaD
Amlodipine—CACNB2—Transmission across Chemical Synapses—MDM2—muscle cancer	3.06e-05	0.00366	CbGpPWpGaD
Amlodipine—CACNA1D—Metabolism—FH—muscle cancer	3e-05	0.00359	CbGpPWpGaD
Amlodipine—CACNA1S—Developmental Biology—FOXO1—muscle cancer	2.88e-05	0.00345	CbGpPWpGaD
Amlodipine—CYP2C8—Arachidonic acid metabolism—PTGS2—muscle cancer	2.85e-05	0.00341	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	2.72e-05	0.00325	CbGpPWpGaD
Amlodipine—CACNA1C—Metabolism—FH—muscle cancer	2.64e-05	0.00315	CbGpPWpGaD
Amlodipine—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	2.62e-05	0.00313	CbGpPWpGaD
Amlodipine—CACNB2—Developmental Biology—FOXO1—muscle cancer	2.47e-05	0.00296	CbGpPWpGaD
Amlodipine—SMPD1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.39e-05	0.00286	CbGpPWpGaD
Amlodipine—CACNB2—Neuronal System—MDM2—muscle cancer	2.34e-05	0.0028	CbGpPWpGaD
Amlodipine—CACNA1D—Developmental Biology—FOXO1—muscle cancer	2.34e-05	0.0028	CbGpPWpGaD
Amlodipine—CYP2C9—Arachidonic acid metabolism—PTGS2—muscle cancer	2.32e-05	0.00277	CbGpPWpGaD
Amlodipine—CYP1A2—Tryptophan metabolism—MDM2—muscle cancer	2.2e-05	0.00263	CbGpPWpGaD
Amlodipine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	2.12e-05	0.00253	CbGpPWpGaD
Amlodipine—CA1—Metabolism—MED12—muscle cancer	2.07e-05	0.00248	CbGpPWpGaD
Amlodipine—CACNA1C—Developmental Biology—FOXO1—muscle cancer	2.06e-05	0.00246	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	1.99e-05	0.00238	CbGpPWpGaD
Amlodipine—CYP1A2—Arachidonic acid metabolism—PTGS2—muscle cancer	1.98e-05	0.00237	CbGpPWpGaD
Amlodipine—CA1—Metabolism—ENO2—muscle cancer	1.89e-05	0.00226	CbGpPWpGaD
Amlodipine—CACNA1S—Axon guidance—VEGFA—muscle cancer	1.84e-05	0.0022	CbGpPWpGaD
Amlodipine—CACNB2—Metabolism—MED12—muscle cancer	1.79e-05	0.00214	CbGpPWpGaD
Amlodipine—CYP3A4—Tryptophan metabolism—MDM2—muscle cancer	1.7e-05	0.00203	CbGpPWpGaD
Amlodipine—CACNA1D—Metabolism—MED12—muscle cancer	1.7e-05	0.00203	CbGpPWpGaD
Amlodipine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	1.67e-05	0.002	CbGpPWpGaD
Amlodipine—CACNB2—Metabolism—ENO2—muscle cancer	1.63e-05	0.00195	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—FH—muscle cancer	1.62e-05	0.00193	CbGpPWpGaD
Amlodipine—CACNB2—Axon guidance—VEGFA—muscle cancer	1.58e-05	0.00189	CbGpPWpGaD
Amlodipine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	1.57e-05	0.00187	CbGpPWpGaD
Amlodipine—CACNA1D—Metabolism—ENO2—muscle cancer	1.55e-05	0.00185	CbGpPWpGaD
Amlodipine—CACNA1D—Axon guidance—VEGFA—muscle cancer	1.49e-05	0.00179	CbGpPWpGaD
Amlodipine—CACNA1C—Metabolism—MED12—muscle cancer	1.49e-05	0.00178	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—FH—muscle cancer	1.48e-05	0.00177	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.4e-05	0.00167	CbGpPWpGaD
Amlodipine—CACNA1C—Metabolism—ENO2—muscle cancer	1.36e-05	0.00162	CbGpPWpGaD
Amlodipine—ABCB1—Allograft Rejection—VEGFA—muscle cancer	1.36e-05	0.00162	CbGpPWpGaD
Amlodipine—CACNA1S—Developmental Biology—VEGFA—muscle cancer	1.31e-05	0.00157	CbGpPWpGaD
Amlodipine—CACNA1C—Axon guidance—VEGFA—muscle cancer	1.31e-05	0.00157	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.28e-05	0.00153	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—FH—muscle cancer	1.19e-05	0.00143	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—FH—muscle cancer	1.17e-05	0.0014	CbGpPWpGaD
Amlodipine—CACNB2—Developmental Biology—VEGFA—muscle cancer	1.13e-05	0.00135	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—FH—muscle cancer	1.1e-05	0.00132	CbGpPWpGaD
Amlodipine—CACNA1D—Developmental Biology—VEGFA—muscle cancer	1.07e-05	0.00128	CbGpPWpGaD
Amlodipine—SMPD1—Metabolism—PTGS2—muscle cancer	1.07e-05	0.00127	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.04e-05	0.00125	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—FH—muscle cancer	1.01e-05	0.00121	CbGpPWpGaD
Amlodipine—CACNA1C—Developmental Biology—VEGFA—muscle cancer	9.37e-06	0.00112	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—MED12—muscle cancer	9.13e-06	0.00109	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	8.92e-06	0.00107	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	8.82e-06	0.00105	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—FH—muscle cancer	8.81e-06	0.00105	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	8.5e-06	0.00102	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—MED12—muscle cancer	8.36e-06	0.001	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—ENO2—muscle cancer	8.32e-06	0.000995	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—FH—muscle cancer	8.3e-06	0.000993	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—FH—muscle cancer	8.23e-06	0.000984	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—ENO2—muscle cancer	7.63e-06	0.000912	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—FH—muscle cancer	7.03e-06	0.000841	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—MED12—muscle cancer	6.75e-06	0.000807	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	6.7e-06	0.000801	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—MED12—muscle cancer	6.6e-06	0.000789	CbGpPWpGaD
Amlodipine—CA1—Metabolism—PTGS2—muscle cancer	6.58e-06	0.000787	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—MED12—muscle cancer	6.23e-06	0.000745	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—ENO2—muscle cancer	6.15e-06	0.000736	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—ENO2—muscle cancer	6.01e-06	0.000719	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—MED12—muscle cancer	5.71e-06	0.000683	CbGpPWpGaD
Amlodipine—CACNB2—Metabolism—PTGS2—muscle cancer	5.69e-06	0.00068	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—ENO2—muscle cancer	5.68e-06	0.00068	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—FH—muscle cancer	5.43e-06	0.000649	CbGpPWpGaD
Amlodipine—CACNA1D—Metabolism—PTGS2—muscle cancer	5.39e-06	0.000644	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—ENO2—muscle cancer	5.21e-06	0.000623	CbGpPWpGaD
Amlodipine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	5.06e-06	0.000605	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—MED12—muscle cancer	4.98e-06	0.000595	CbGpPWpGaD
Amlodipine—CACNA1C—Metabolism—PTGS2—muscle cancer	4.73e-06	0.000566	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—MED12—muscle cancer	4.69e-06	0.000561	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—MED12—muscle cancer	4.65e-06	0.000556	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—ENO2—muscle cancer	4.54e-06	0.000543	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	4.44e-06	0.000531	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—ENO2—muscle cancer	4.28e-06	0.000511	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—ENO2—muscle cancer	4.24e-06	0.000507	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	4.07e-06	0.000487	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—MED12—muscle cancer	3.97e-06	0.000475	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—ENO2—muscle cancer	3.62e-06	0.000433	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	3.32e-06	0.000397	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—MED12—muscle cancer	3.07e-06	0.000367	CbGpPWpGaD
Amlodipine—CYP3A7—Metabolism—PTGS2—muscle cancer	2.9e-06	0.000347	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.83e-06	0.000339	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—ENO2—muscle cancer	2.8e-06	0.000334	CbGpPWpGaD
Amlodipine—CYP2A6—Metabolism—PTGS2—muscle cancer	2.66e-06	0.000318	CbGpPWpGaD
Amlodipine—CYP2B6—Metabolism—PTGS2—muscle cancer	2.14e-06	0.000256	CbGpPWpGaD
Amlodipine—CYP3A5—Metabolism—PTGS2—muscle cancer	2.09e-06	0.000251	CbGpPWpGaD
Amlodipine—CYP1A1—Metabolism—PTGS2—muscle cancer	1.98e-06	0.000237	CbGpPWpGaD
Amlodipine—CYP2C8—Metabolism—PTGS2—muscle cancer	1.81e-06	0.000217	CbGpPWpGaD
Amlodipine—ABCB1—Metabolism—PTGS2—muscle cancer	1.58e-06	0.000189	CbGpPWpGaD
Amlodipine—CYP2D6—Metabolism—PTGS2—muscle cancer	1.49e-06	0.000178	CbGpPWpGaD
Amlodipine—CYP2C9—Metabolism—PTGS2—muscle cancer	1.48e-06	0.000177	CbGpPWpGaD
Amlodipine—CYP1A2—Metabolism—PTGS2—muscle cancer	1.26e-06	0.000151	CbGpPWpGaD
Amlodipine—CYP3A4—Metabolism—PTGS2—muscle cancer	9.74e-07	0.000116	CbGpPWpGaD
